Skip to main content

VBS News

The Ohio State University College of Veterinary Medicine is proud to announce the appointment of six endowed positions:
Researchers at The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have been awarded a five-year, $10 million grant from the National Cancer Institute in the National Institutes of Health to study the long-term, longitudinal impact of COVID-19 on firs
By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.
Dr. Prosper Boyaka received the CVM Zoetis Award for Veterinary Research Excellence.  Dr. Jerry Masty received the CVM Zoetis Distinguished Veterinary Teacher Award. 
Dr. Shan-Lu Liu is co-organizer of the first-ever Midwest Virology Symposium being held October 11-13, 2019 at The Ohio State University Infectious Diseases Institute. The goal is to bring together researchers from the Midwest region of the U.S.
The 5th Brazilian Congress of Veterinary Pathology was held in Ribeirao Preto, Brazil from July 15th-18th.  The Congress was hosted by the Brazilian College of Veterinary Pathology. Dr.
Dr. Yasuko Rikihisa, University Distinguished Professor in the Department of Veterinary Biosciences, was recently awarded $429,000 from the National Institute of Allergy and Infectious Diseases to fund a R21 grant titled "Inhibition of Ehrlichial Infection by Intracellular Nanobody."  
Study could contribute to new therapies A new study reveals details about the evolutionary contest between HIV and the human immune system that could one day improve treatment.
Amit Sharma, PhD, Assistant Professor, Veterinary Biosciences, received a two year, $497,836 R00 grant from NIH-National Institute of Allergy and Infectious Diseases entitled “Host innate immune response as a barrier to cross-species retrovirus transmission."